Latest Breaking News On - நோயாளிகள் அப்பால் - Page 5 : comparemela.com

(1) DJ EQS-News: Antengene Announces XPO1 Inhibitor Selinexor Prescribed for the First Time in the Pilot Zone of Hainan Province and Authorized to be Expanded Beyond the Pilot Zone for Outpatient Treatment EQS-News / 29/04/2021 / 11:36 UTC+8 Antengene Announces XPO1 Inhibitor Selinexor Prescribed for the First Time in the Pilot Zone of Hainan Province and Authorized to be Expanded Beyond the Pilot Zone for Outpatient Treatment With the official release and implementation of the Overall Plan for the Construction of Hainan Free Trade Port, patient can now access global innovative medicines in mainland China. Recently, the global first-in-class selective inhibitor of nuclear export (SINE) compound, selinexor (XPOVIO(R)), was prescribed for the first time in mainland China at the Boao Super Hospital in Boao Lecheng Pilot Zone and has been authorized to be expanded beyond the Pilot Zone for the outpatient treatment of relapsed or refractory multiple myeloma (rrMM). Prescribing selinex

Hainan provinceHong kongBoao lechengHongxia yaoAsia pacificNational comprehensive cancer network nccnr guidelinesHematological lymphoma department of hainan cancer hospitalAntengene corporation limitedPeople dailyKaryopharm therapeutics incBoao lecheng international medical tourism pilot zoneFinancial pressPatient programName patient programHainan chengmei medicine co ltdNational comprehensive cancer network